← Oncology Approval Tracker

FDA DECISION ·

Datroway

datopotamab deruxtecan-dlnk · Daiichi Sankyo

FDA approvalNew therapyBreast cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

For adults with unresectable or metastatic HR-positive, HER2-negative breast cancer after endocrine-based treatment and chemotherapy for that advanced disease.

LAMPGEN ANALYSIS

Why it matters

The first Datroway approval introduced a TROP2-directed antibody–drug conjugate after endocrine therapy and chemotherapy.

What research teams should watch

Plan oral and ocular supportive measures and give patients a route to report early signs of pneumonitis.

PRIMARY RECORDS

Sources